分类： 未分类

厦门市应对新冠肺炎疫情工作指挥部办公室

关于加强冬春季疫情防控工作的公告

当前，新冠肺炎疫情防控形势严峻复杂，为进一步做好疫情防控工作，切实保障广大人民群众生命安全和身体健康，现就加强我市冬春季疫情防控工作公告如下：

一、强化个人防护。请广大市民自觉加强自我防护措施，外出活动应佩戴口罩，保持1米以上的社交距离，养成勤洗手、咳嗽打喷嚏注意遮挡等良好卫生习惯，尽量减少不必要的人群聚集活动。加强个人健康监测，如出现发热、咳嗽等症状，应严格佩戴口罩，第一时间到我市公布的定点医院发热门诊就诊。

二、强化公共场所管理。商场、超市、农贸(集贸)市场、餐馆、图书馆、文化馆、博物馆、美术馆、公园、景区、医院、养老院、机场、火车站、剧院、电影院、娱乐场所等公共场所要加强管理，严格落实“验码、测温、不聚集、戴口罩、清洁消毒、通风换气”等措施，排队区域须设置“一米线”，引导市民保持社交距离。上述公共场所管理单位应在人员聚集区域安排专门工作人员加强疏导，尽量减少和避免人员聚集。

严控景区和公共场所接待规模，继续执行景区预约常态化管理，实现限量、预约、错峰入园，景区接待游客量不超过最大承载量的75%，剧院、娱乐场所等公共场所继续执行接纳消费者人数不超过核定人数75%的政策。

三、规范乘坐交通工具。乘坐飞机、动车、地铁、公交、BRT、轮渡、出租车（含网约车）、电梯等交通工具的乘客必须全程规范佩戴口罩，不戴口罩者不得乘坐。交通工具持有单位或个人要加强交通工具管理，增加清洁、通风、消毒频次，公交、BRT、轮渡、出租车（含网约车）运行过程中要尽量保持通风状态。

四、严控聚集性活动

大型活动监管。严格审批监管文艺演出、体育比赛、展览展销等活动，严控节日祈福、庙会灯会等群众性活动，严格人流控制，划设进出通道，做好体温监测和应急处置准备，对不符合疫情防控和安全要求的活动不予批准。不安排宗教活动场所内的聚集性活动，不批准开展大型宗教活动，民间信仰活动场所参照上述要求执行。

会议、聚会等活动。举办会议、聚会等活动应当控制人数，尽量举办线上会议或视频会议。原则上不举办集体团拜、企业年会、尾牙聚餐以及各类大规模群体性聚餐活动。50人以上活动应当制定防控方案，报属地区应对疫情工作指挥部审批，坚持“谁组织、谁负责”，由组织单位承担疫情防控主体责任。

群体性聚餐活动。实行喜事缓办、丧事简办，丧事办理需报居委会（村委会）备案，居委会（村委会）指定专人参与活动全程管理。提倡家庭私人聚会聚餐等控制在10人以下，做好个人防护，有流感等症状尽量不参加。对于合餐顾客，餐饮服务单位应提供“一菜一公筷、一汤一公勺”或者“一人一公筷，一人一公勺”服务，有条件的餐馆要积极推广分餐制。

五、倡导留厦过年。请广大市民非必要不离厦、非必要不出境，鼓励在厦过春节，尽量减少人员流动。鼓励企事业单位根据生产、工作情况和职工意愿，灵活安排休假，引导职工群众错峰返乡返岗，倡导大中专学生和职工群众留厦过年,做好节假日留校学生管理服务，指导督促用人单位依法依规做好加班工资支付和调休等工作，对留厦过年的大中专学生和职工群众给予温馨关怀。

六、强化社区排查管控。居委会（村委会）要采取多种形式宣传、引导返厦人员主动报告、登记，要及时对外公布电话或其他登记渠道，认真做好人员摸排和网格化管理。

自1月1日以来，来自或途经国内疫情中高风险地区所在城市（含已经调整为低风险地区）的返厦人员，应在抵厦后第一时间向居住所在地居委会（村委会）报告，在1月15日前已抵厦的需在24小时内向居委会（村委会）报告。居委会（村委会）要按照规定落实核酸检测和健康管理（持有七日内核酸检测阴性证明的，可不再进行核酸检测）。

从国内其他口岸入境的返厦人员，应在抵厦后第一时间向居住所在地居委会（村委会）报告。居委会（村委会）要按照规定落实健康管理。

七、强化责任与检查。各区要落实属地责任，各部门要落实主管责任，各单位要落实主体责任，各家庭个人要落实自我防护责任。各区、各部门要对本公告规定落实情况进行常态化检查，及时发现问题，及时督促整改到位。对违反上述规定的，依法追究责任。

以上措施自发布之日起实施至2021年3月31日。后续本市将根据国内外疫情形势，及时动态调整相关防控措施和实施时间。

厦门市应对新冠肺炎疫情工作指挥部办公室

2021年1月15日

Faced with soaring rates of coronavirus infection and more doses of vaccine in freezers than in arms, New Jersey officials made a calculated choice.

They opened the floodgates of vaccine eligibility on Thursday to about 4.5 million additional residents: those 65 and older and younger people with underlying health problems, including cancer, heart conditions and diabetes — diseases that can lead to severe complications from Covid-19.

As part of the expansion, New Jersey also became only the second state in the country to open vaccinations to another high-risk group — smokers. As is true for all Covid-19 vaccinations in New Jersey, no documentation of an underlying health condition is required.

The announcement came a day after the Trump administration told states to expand eligibility and to quickly use existing vaccine or risk losing future allocations.

But New Jersey’s decision to immediately adopt all of the recommendations by the Centers for Disease Control and Prevention for priority vaccination puts these groups ahead of some essential workers — including teachers. The move has contributed to a sense of confusion and anger among those who now find themselves at the back of the line for inoculation.

It has also expanded competition for shots at a time when many people in the first priority groups continue to have trouble making appointments and navigating the overburdened scheduling systems of vaccine clinics.

“The supply is not sufficient. That’s the challenge,” said Jen Kates, director of global health and H.I.V. policy for the Kaiser Family Foundation, a health policy research organization. “It has to be a calibrated balance. You want people to want to come in to be vaccinated, but you don’t want them to have to wait so long they get frustrated.”

The C.D.C. includes smoking on a list of medical conditions that it recommends be prioritized in state vaccination programs because of the higher risk of serious complications from Covid-19. But to date, only one other state, Mississippi, appears to have authorized vaccinations for people younger than 65 based solely on the criterion that they smoke cigarettes.

On Friday, Gov. Philip D. Murphy called criticism that smokers were jumping the line a “cheap shot” and a “false narrative,” noting that the state is hewing closely to C.D.C. guidelines.

At least 13 people have died in Norway due to side effects of the Pfizer/BioNTech Covid-19 vaccine, the national medicines regulator has revealed. All were frail and elderly people who had unusually strong reactions to the jabs.
Norway launched its Covid-19 immunization program on December 27, including residents of nursing homes on the priority list. Since then, 23 people have died shortly after receiving the injections. Norwegian medics are evaluating all such cases and have linked 13 of them to the side effects of the vaccine, according to local media.

“We do not see anything alarming with these figures. All deaths are in elderly and frail people with underlying diseases,” Dr. Steinar Madsen, the medical director of the national drug regulator, the Norwegian Medicines Agency, explained.

For context, Norway has a population of over five million. Madsen previously said that between 350 and 400 people die at the country’s nursing homes each week as he predicted that some elderly people may not react well to the vaccine.

In addition to those who died, there were also 29 vaccine recipients who had developed significant side effects, including nine serious cases and seven mild ones, the official reported. All Covid-19 vaccines can sometimes cause adverse reactions like fever and nausea.
The Norwegian Public Health Institute updated its Covid-19 vaccination guidelines earlier this week to reflect the new data. The document now instructs medics to thoroughly evaluate nursing home residents before giving them the vaccine. For very ill people who are not expected to live long, the benefit of the jab “may be marginal or negligible,” the guidelines say.

Europeans must carry certificates proving they’ve been vaccinated against Covid-19 to travel, EC president Ursula von der Leyen told Portuguese media – likely shocking Europeans who’d never heard of such a rule.
Von der Leyen sprung the idea of a “mutually recognized vaccination certificate” as a “medical requirement” for travel on Thursday in the course of praising a similar plan outlined to her in a letter from Greek PM Kyriakos Mitsotakis.

“It is a medical requirement to have a certificate proving that you have been vaccinated,” von der Leyen told Portuguese reporters.

While Mitsotakis’ plan was not meant to be “compulsory or a prerequisite for travel,” von der Leyen seemed to be leaning in that direction, repeating that “we have to have a medical requirement that proves that people have been vaccinated.” The idea of an EU-wide vaccine certificate “is a political and legal decision that should be discussed at a European level,” she continued emphatically.

This was no doubt news to Europeans unfamiliar with the contents of Mitsotakis’ letter. The Greek leader wrote that it was “urgent to adopt a common understanding on how a vaccination certificate should be structured so as to be accepted in all member states,” and an EU-wide meeting is scheduled for Thursday, at which point Mitsotakis is expected to make the case for certificates “facilitating the freedom of movement of persons who have been vaccinated against Covid-19.”

“It is urgent to adopt a common understanding on how a vaccination certificate should be structured so as to be accepted in all member states,” he wrote. Greece plans to issue digital vaccine certificates to every resident who receives the jab.

Seemingly brainstorming ways to incentivize the uptake of such certificates without imposing an explicit mandate, von der Leyen suggested on Friday that they be combined with Covid-19 tests for those unable to access the vaccine in a timely fashion. Such a package would allow for greater travel to warm-weather destinations – a must for EU member states with tourism-dependent economies concerned that a second year in a row without pleasure travel will destroy them.

Brussels insists it has obtained enough of the Pfizer-BioNTech and Moderna vaccines to inoculate every European , and von der Leyen has forbidden member states from making their own side deals. However, defiant Hungary has already reached a deal to buy China’s Sinopharm vaccine, with Hungarian Prime Minister Viktor Orban saying on Friday that the local regulators must act“responsibly,” but “quickly” to approve the Chinese-made jab. Budapest has been negotiating with Russia for a supply of Sputnik V as well, complaining that the sluggish speed of the EU program will require Covid-19 restrictions to remain in place for “several more months” of unnecessary economic suffering. Nor is it the only member nation that has complained about the pace of the EU’s vaccination rollout.

There’s also confusion about recently-Brexited British citizens’ compatibility with an EU-wide vaccine passport program – or whether the UK is planning to issue the certificates at all. Conservative MP Michael Gove claimed vaccine passports were “not the plan,” a statement echoed by PM Boris Johnson’s vaccine czar Nadhim Zahawi – but not until after Zahawi had already admitted London was “looking at the technology.”

Privacy advocates have warned that vaccination certificates could easily snowball into intrusive global digital IDs, complete with discrimination based on medical conditions, rationing of benefits, and thorny human rights issues stemming from requiring people to be injected with what remain largely-untested pharmaceutical compounds. Thousands of recipients of the Pfizer-BioNTech and Moderna jabs have experienced incapacitating side effects.

Norway is currently investigating the death of 23 nursing home residents who passed away shortly after receiving Pfizer jabs, with 13 of the cases being linked to the side effects of the vaccine.

Meanwhile, Spain plans to keep a database of vaccine refusers which it will share with other “European partners,” effectively relegating vaccine skeptics to second-class citizens.

挪威当局表示，目前让高龄和患末期重症者接种疫苗可能存在高风险。挪威在开始展开疫苗接种之后，短时间内已有23人死亡，他们都是80岁以上免疫力较弱的老年群体。

挪威医疗机构透露，他们对其中13名死者遗体解剖后发现，副作用可能导致这些体弱年老者出现严重症状死亡。

挪威Norway Today新闻网站周四（1月14日）报道，挪威药品管理局首席医师西格德指出，报告显示，mRNA（信使核糖核酸）疫苗常见的副作用如发烧、恶心等，可能是导致这些体弱老人死亡的原因。

彭博社报道，挪威公共卫生局说：“对那些非常虚弱者而言，即使是相对轻微的疫苗副作用，都会造成严重后果。对那些剩余寿命很短的人来说，疫苗所带来的益处可能微不足道或没有关连。”

挪威政府至今已为约3万3000人施打第一剂疫苗，这些人包括被视为高风险群体的老年人。挪威注射的多数是美国辉瑞与德国BioNTech联合开发的冠病疫苗。挪威目前也将开始接种由莫德纳研发的疫苗。

针对挪威的情况，辉瑞和BioNTech都没有针对媒体的询问置评。辉瑞的疫苗去年底获批后已经广泛使用。

冠病疫苗引发的过敏反应，至今仍不常见。在美国，当局从去年12月14日至23日通报了21起严重过敏反应例子。当时，美国已使用约190万剂辉瑞疫苗。美国疾病控制与预防中心（CDC）表示，过敏情况是每100万剂出现11.1次。

在法国，一名体弱的病人在接种疫苗后，在养院死去。但法国当局表示，该病人有病史，没有迹象显示死亡与疫苗有关。